CYTOKINE 30-PLEX HUMAN PANEL (AMBIS 2230371)

This is a Sources Sought notice SS-NIAID-24-2230371 for domestically manufactured products only. This is NOT a solicitation for proposals, proposal abstracts, or quotations. Per the Buy American Act and Executive Order 14005, the National Institutes of Allergy & Infectious Disease (NIAID) is seeking information for domestically manufactured products only, Per the requirements under the Buy American Act and requirements relating to Executive Order 14005 entitled: “Ensuring the Future is Made in All of America by All of America’s Workers”, in the event that a nonavailability waiver request submitted through the Made in America Office (MIAO)’s Digital Waiver Portal is required." Respondents must certify in capabilities statement that products are manufactured in the United States.

The purpose of this notice is to obtain information regarding the availability and capability of all U.S manufactured products that are equal to the following product:

Invitrogen Cytokine 30-Plex Human Panel, Catalog number: LHC6003M

https://www.thermofisher.com/order/catalog/product/LHC6003M

Specifications:

Product Type Multiplex Panel

Quantity 100 Tests

Species: Human

Combinability: Combinable

Detection Method: Fluorescent

Conjugate: R-PE

Format: Preconfigured Panel

For Use With (Equipment): Luminex™ Instruments

Product Line: Novex

Protein: Cytokine

Protein Subtype: Cytokines & Receptors

Sample Type: Serum, Plasma, Cell Culture Supernatants

CytoKines: G-CSF, GM-CSF, IFN-α, IFN-γ, IL-1β, IL-1RA , IL-2, IL-2R, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12 (p40/p70), IL-13, IL-15, IL-17, TNF-α

Chemokines: Eotaxin, IP-10, MCP-1, MIG, MIP-1α, MIP-1β, RANTES

Growth factors: EGF, FGF-basic, HGF, VEGF

Capability Statement/Information Sought

All capable vendors should respond with a brief capability statement demonstrating an equal product that is manufactured in the United States by July 19, 2024, by 4:00 PM EST.

Capabilities statement must also include the following information: 1) organization name, address, point of contact, email address, website address, telephone number, UE ID# with an active SAM.gov registration, and a tailored capability statements addressing the particulars of this effort, with appropriate documentation supporting claims of capability.

Submission Instructions

Interested businesses who consider themselves qualified to provide an equal product that is manufactured in the United States for the above-listed product are invited to submit a response to this Sources Sought Notice by July 19, 2024, by 4:00 PM EST.   

All quotations and required documents must be submitted via the NIAID electronic Simplified Acquisition Submission System (eSASS) website at https://esass.nih.gov. All vendors must register in the eSASS system to submit a quotation. Instructions on how to register / submit quotes are included on the website. Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f). All responsible sources may submit an offer that will be considered by this Agency. 

Disclaimer and Important Notes

This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization’s qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a pre-solicitation synopsis and solicitation may be published in Federal Business Opportunities. However, responses to this notice will not be considered adequate responses to a solicitation.

Confidentiality

No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s).